VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 665 filers reported holding VANECK VECTORS ETF TR in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,456,832 | -11.1% | 128,459 | -0.5% | 0.00% | 0.0% |
Q2 2023 | $3,886,418 | -20.1% | 129,074 | -14.1% | 0.00% | 0.0% |
Q1 2023 | $4,862,561 | +14.1% | 150,311 | +1.1% | 0.00% | 0.0% |
Q4 2022 | $4,261,340 | +19.0% | 148,686 | +0.2% | 0.00% | 0.0% |
Q3 2022 | $3,580,000 | -11.1% | 148,435 | +0.9% | 0.00% | 0.0% |
Q2 2022 | $4,026,000 | -28.7% | 147,061 | -0.1% | 0.00% | 0.0% |
Q1 2022 | $5,644,000 | +19.9% | 147,161 | +0.1% | 0.00% | 0.0% |
Q4 2021 | $4,708,000 | +6.7% | 146,991 | -1.8% | 0.00% | 0.0% |
Q3 2021 | $4,413,000 | -13.3% | 149,749 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $5,088,000 | -3.7% | 149,749 | -7.8% | 0.00% | 0.0% |
Q1 2021 | $5,282,000 | -10.6% | 162,504 | -0.9% | 0.00% | -33.3% |
Q4 2020 | $5,909,000 | -7.7% | 164,042 | +0.3% | 0.00% | 0.0% |
Q3 2020 | $6,403,000 | +171.9% | 163,494 | +189.9% | 0.00% | +200.0% |
Q2 2020 | $2,355,000 | +11114.3% | 56,400 | +5964.5% | 0.00% | – |
Q1 2019 | $21,000 | – | 930 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |